NDAORALTABLET, CHEWABLE
Approved
Jun 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IMODIUM MULTI-SYMPTOM RELIEF is a fixed-dose combination of loperamide hydrochloride (an antidiarrheal agent) and simethicone (an antifoaming agent) delivered as a chewable oral tablet. It treats acute diarrhea and associated gastrointestinal symptoms including bloating and gas. Loperamide works by slowing intestinal motility, while simethicone reduces gas-related discomfort.
LOE Approaching
As an OTC product approaching loss of exclusivity with moderate competitive pressure (30/100), expect smaller brand teams focused on maintaining market share through consumer marketing and retail partnerships rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on IMODIUM MULTI-SYMPTOM RELIEF offers limited career growth due to its mature LOE-approaching lifecycle and zero linked job postings. This role is best suited for professionals seeking stable, tactical work in OTC brand management, consumer marketing, or retail partnerships rather than strategic innovation or clinical development.
Brand ManagerSales Representative
Worked on IMODIUM MULTI-SYMPTOM RELIEF at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.